Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
Copyright © 2018 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood sugar; HbA1c, glycosylated hemoglobin; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; MDRD, modification of diet in renal disease; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; sDPP-4, soluble dipeptidyl peptidase-4; CAC, coronary artery calcium; AU, absorbance unit.
aAntihypertensives included angiotensin-converting enzyme (ACE) inhibitor, angiotensin II receptor blocker (ARB), calcium-channel blocker, and thiazides.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycosylated hemoglobin; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; MDRD, modification of diet in renal disease; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; CAC, coronary artery calcium.